BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17324338)

  • 1. Experimental study enhancing the chemosensitivity of multiple myeloma to melphalan by using a tissue-specific APE1-silencing RNA expression vector.
    Yang ZZ; Chen XH; Wang D
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):296-304. PubMed ID: 17324338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition.
    Wang D; Luo M; Kelley MR
    Mol Cancer Ther; 2004 Jun; 3(6):679-86. PubMed ID: 15210853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of the involvement of apurinic/apyrimidinic endonuclease 1 in the resistance to melphalan in multiple myeloma.
    Xie J; Zhang L; Li M; Du J; Zhou L; Yang S; Zeng L; Li Z; Wang G; Wang D
    BMC Cancer; 2014 Jan; 14():11. PubMed ID: 24400589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
    Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
    Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo.
    Xiang DB; Chen ZT; Wang D; Li MX; Xie JY; Zhang YS; Qing Y; Li ZP; Xie J
    Cancer Gene Ther; 2008 Oct; 15(10):625-35. PubMed ID: 18535621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction and identification of a multiple myeloma-specific APE1 siRNA expression vector].
    Yang ZZ; Chen XH; Wang D; Wang G; Xiang DB
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):235-9. PubMed ID: 16875553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
    Zhang HR; Chen JM; Zeng ZY; Que WZ
    J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of APE1/Ref-1 and its regulation on IL-6 and IL-8 in bone marrow stromal cells of multiple myeloma.
    Xie JY; Li MX; Xiang DB; Mou JH; Qing Y; Zeng LL; Yang ZZ; Guan W; Wang D
    Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):385-93. PubMed ID: 21030352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer.
    Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target.
    Wen X; Lu R; Xie S; Zheng H; Wang H; Wang Y; Sun J; Gao X; Guo L
    Cancer Biomark; 2016 Sep; 17(3):313-322. PubMed ID: 27802207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
    Chen S; Xiong G; Wu S; Mo J
    Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.
    Li Z; Qing Y; Guan W; Li M; Peng Y; Zhang S; Xiong Y; Wang D
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):777-86. PubMed ID: 25107571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB.
    Greco C; D'Agnano I; Vitelli G; Vona R; Marino M; Mottolese M; Zuppi C; Capoluongo E; Ameglio F
    Int J Immunopathol Pharmacol; 2006; 19(1):67-79. PubMed ID: 16569345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
    Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
    Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcoma.
    Jiang X; Shan J; Dai N; Zhong Z; Qing Y; Yang Y; Zhang S; Li C; Sui J; Ren T; Li M; Wang D
    Cancer Sci; 2015 Oct; 106(10):1394-401. PubMed ID: 26250694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
    Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR
    Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC.
    Malfatti MC; Gerratana L; Dalla E; Isola M; Damante G; Di Loreto C; Puglisi F; Tell G
    J Exp Clin Cancer Res; 2019 Jul; 38(1):309. PubMed ID: 31307523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
    Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR
    Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
    Luo M; Kelley MR
    Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.